3American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum, 2002,46:328-346.
4Wiesenhutter CW, Irish BL, Bertram JH. Treatment of patients with refractory rheumatoid arthritis with extracorporeal protein a immunoadsorption columns: a pilot trial. J Rheumatol, 1994,21:804-812.
5Caldwell J,Gendreau RM, Furst D,et aL A pilot study using a staph protein A column (Prosorha) to treat refractory rheumatoid arthritis.J Rheumatol, 1999,26 : 1657-1662.
6Furst D, Felson D, Thoren G, et al. Immunoadsorption for the treatment of rheumatoid arthritis : final results of a randomized trial.Prosorba Trial Investigators, Ther Apher,2000,4:363-373.
7Matic G, Bosch T, Ramlow W. Background and indications for protein A based extracorporeal immunoadsorption. Ther Apher,2001,5:394-403.
8Lewis EJ, Hunsicker LG, Lan SP, et al. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med, 1992, 326:1373-1379.
9Suzuki K. The role of immunoadsorption using dextran-sulfate cellulose columns in the treatment of systemic lupus erythematosus.Ther Apher, 2000,4:239-243.
10Pfueller B, Wolbart K, Bruns A, et al. Successful treatment of patients with systemic lupus erythematosus by immunoadsorption witha C1q column: a pilot study. Arthritis Rheum,2001,44:1962-1963.
二级参考文献10
1[1]DJ Wallace. Apheresis for lupus erthematosus. Lupus, (1999)8:174- 180
2[2]Csipo I, Kiss E, soltesz P, et al. Effect of plasmapheresis on ligand binding capacity and expression of erythrocyte complement receptor type Ⅰ (CR Ⅰ )of patient with systemic lupus erythematosus. Clin Exp Immunol, 1999,118(3) :458 - 464
3[3]Jones JV. Response to apheresis:problems of assessment in immune disease. Clin Nephrol, 1986,26 (Suppl 1 ) :70 - 75
4[4]Csipo l,kavai M, kiss E, et al. Serum complememt activation of SLE patients during plasmapheresis. Autoimmunity, 1997, 25 ( 3 ):139 - 146
5[5]Funauchi M, lkoma S, Enomoto H, et al. High affinity anti DNA antibody parallels clinical course of immunoadsorption therapy for systemic lupus erythematosus. Intern Med, 1996,35(5) :367 - 372
6[6]Schiel R, Bambauer R, Lataza R, et al. Cycloporin and plasmapheresis in treatment of progressivae systemic lupus erythematosus.Transfus Sci, 1997, 18( 1 ) :91 - 97
7[7]Sharon Z, Roberts JL, Fennel JS, et al. Plasmapheresis in lupus nephritis. Plasma Ther, 1982,3:165 - 169
8[8]Lewis EJ, Hunsicker LG, Lan SP, et al. A controlled trail of plasmapheresis therapy in severe lupus nephritis. N Engl J Med, 1992,326:1373 - 1379
9[9]Wallace DJ. Plasmapheresis for lupus nephritis. N Engl J Med,1992,327:1029
10[10]Gerraty RP, McKelvie PA, Byrne E. Aseptic meningoencephalitis in primary Sj? gren' s syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy. Acta Neurol Scand, 1993,88(4): 309- 11
